Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anhedonia in schizophrenia.

Daniel H Wolf1

  • 1Department of Psychiatry, Neuropsychiatry Program, University of Pennsylvania, 10 Gates Building, 3400 Spruce Street, Philadelphia PA 19104, USA. danwolf@bbl.med.penn.edu

Current Psychiatry Reports
|August 2, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cannabis use and glutamate across the psychosis spectrum: in vivo evidence from 7T proton magnetic resonance spectroscopy.

Molecular psychiatry·2026
Same author

An open, fully-processed data resource for studying mood and sleep variability in the developing brain.

Aperture neuro·2026
Same author

Premorbid adjustment problems, negative symptoms, and cognitive impairment in a large international sample at clinical high risk for psychosis: Findings from the Accelerating Medicines Partnership-Schizophrenia.

Schizophrenia bulletin·2026
Same author

The PMADS Project: A Longitudinal Multimodal Cohort Study to Understand Risk for Perinatal Mood and Anxiety Disorders.

bioRxiv : the preprint server for biology·2026
Same author

Impaired intrinsic motivation in psychosis risk relates to ventral striatum activation to self-generated reinforcement signals.

Schizophrenia research·2026
Same author

Brain aging in bipolar disorder using a neuroimaging and machine learning-derived metric: Findings from the ENIGMA BD Working Group.

Journal of affective disorders·2026

Anhedonia, a reduced capacity for pleasure, is common in schizophrenia and poorly understood. New research initiatives aim to improve assessment and treatment for this challenging symptom.

Area of Science:

  • Psychiatry and Neuroscience
  • Clinical Psychology

Background:

  • Anhedonia, characterized by reduced pleasure capacity, is a long-recognized symptom of schizophrenia.
  • Despite its significance, anhedonia remains poorly understood due to schizophrenia's complexity and the challenges of studying subjective experiences.

Purpose of the Study:

  • To review current understanding and recent advancements in the epidemiology, phenomenology, etiology, and treatment of anhedonia in schizophrenia.
  • To identify critical areas for future research and intervention development.

Main Methods:

  • Literature review synthesizing existing research on anhedonia in schizophrenia.
  • Analysis of factors contributing to the poor understanding of anhedonia, including phenotypic heterogeneity and methodological challenges.

Related Experiment Videos

Main Results:

  • Anhedonia is prevalent in schizophrenia and has substantial negative impacts on patients.
  • Current treatment strategies for anhedonia in schizophrenia are largely insufficient.

Conclusions:

  • There is a critical need for improved assessment tools and a deeper understanding of the biological and psychosocial mechanisms underlying anhedonia.
  • Novel pharmacologic and psychosocial interventions are required to effectively manage anhedonia in schizophrenia.
  • The Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) initiative offers optimism for future progress.